Principal Financial Group’s Dianthus Therapeutics DNTH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-37,350	Closed	-$1.73M	–	2540
2022 Q1	$1.73M	Buy	37,350 +58	+0.2%	+$3.17K	﹤0.01%	1884
2021 Q4	$2.64M	Buy	37,292 +7,142	+24%	+$718K	﹤0.01%	1818
2021 Q3	$3.51M	Buy	30,150 +469	+2%	+$54.6K	﹤0.01%	1780
2021 Q2	$4.64M	Buy	29,681 +11,481	+63%	+$2.11M	﹤0.01%	1735
2021 Q1	$3.45M	Buy	18,200 +2,337	+15%	+$393K	﹤0.01%	1755
2020 Q4	$1.99M	Buy	15,863 +913	+6%	+$104K	﹤0.01%	1801
2020 Q3	$1.63M	Buy	14,950 +475	+3%	+$56.3K	﹤0.01%	1775
2020 Q2	$1.74M	Buy	14,475 +37	+0.3%	+$5.21K	﹤0.01%	1722
2020 Q1	$1.45M	Hold	14,438	–	–	﹤0.01%	1670
2019 Q4	$3.5M	Sell	14,438 -16	-0.1%	-$2.99K	﹤0.01%	1621
2019 Q3	$2.37M	Sell	14,454 -134	-0.9%	-$25.5K	﹤0.01%	1693
2019 Q2	$3.44M	Sell	14,588 -143	-1%	-$35.4K	﹤0.01%	1629
2019 Q1	$3.88M	Sell	14,731 -2,144	-13%	-$370K	﹤0.01%	1620
2018 Q4	$1.54M	Sell	16,875 -8,816	-34%	-$1.2M	﹤0.01%	1749
2018 Q3	$4.94M	Buy	25,691 +76	+0.3%	+$16K	﹤0.01%	1610
2018 Q2	$5.53M	Buy	+25,615	New	+$5.78M	0.01%	1564